Labelling requirements for non-prescription drugs guidance document
The safe use of non-prescription drugs depends on consumers being able to identify the desired product and also being able to understand and act upon the information presented. The label and package are the first points of interaction between a health product and a consumer or healthcare professional. Prior to the implementation of the Plain Language Labelling (PLL) initiative, the general practice in Canada was to present key information within blocks of text on the product label. This guidance document provides prescriptive information on the design specifications, required sections of the CDFT, and labelling content.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Labelling requirements for non-prescription drugs guidance documentHTMLEnglish publication HTML
Labelling requirements for non-prescription drugs guidance documentHTMLFrench publication HTML